InvestorsHub Logo
Followers 971
Posts 383037
Boards Moderated 6
Alias Born 06/24/2011

Re: BlazingStocks post# 2687

Wednesday, 06/07/2023 8:21:55 AM

Wednesday, June 07, 2023 8:21:55 AM

Post# of 2792
Great to hear: "The presentation displayed our Phase I data, which included our safety data at various dose cohorts and early outcomes data, was well received and viewed by interested parties at the conference. In summary, it showed the drug to be very safe at 5 ascending dose cohorts and definitive bioactivity in several patients," stated Dr. Mini Gill who presented for the Company.

$NBIO
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News